Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG

Zoran Rankovic1, Jiaqiang Cai, Jennifer Kerr

  • 1Merck Research Laboratories, MSD, Newhouse, Lanarkshire, ML1 5SH Scotland, United Kingdom. zoran.rankovic@merck.com